Marshall Fordyce, PRESIDENT AND CEO at Vera Therapeutics, Inc. (VERA), sold 44,315 shares at $36.80 ($1.6M) on 2024-08-28, disclosed to the SEC on 2024-08-30.
Scheduled sale ($1.6M) by PRESIDENT AND CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.80 | 14,925 | $549K | 33.6% |
| 2 | $36.82 | 13,995 | $515K | 31.6% |
| 3 | $36.82 | 13,995 | $515K | 31.6% |
| 4 | $37.53 | 700 | $26K | 1.6% |
| 5 | $37.54 | 700 | $26K | 1.6% |
| Total | $36.84 avg | 44,315 |
| $1.6M |
| 100% |
| Filing → |
| VERA | SELL | 2026-07-09 | $2.0M | — | Filing → |
| VERA | SELL | 2026-06-24 | $702K | — | Filing → |
| VERA | SELL | 2026-05-13 | $680K | — | Filing → |